ClinicalTrials.Veeva

Menu

Inflammatory Markers and Resistant Depression (InDep)

C

Centre Hospitalier Universitaire de Besancon

Status

Unknown

Conditions

Depression

Treatments

Behavioral: psychometric scales
Procedure: blood sample

Study type

Interventional

Funder types

Other

Identifiers

NCT02847533
API/2014/50

Details and patient eligibility

About

This study focuses on blood inflammatory markers (pro-inflammatory cytokines, anti-inflammatory cytokines, monocytes costimulation molecules) in patients with resistant unipolar depression in comparison with non-resistant unipolar depressed patients.

Enrollment

108 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • group 1: Patients with resistant MDD (at least 2 failed treatments for the current episode) ,current treatment with IRS or IRSNA,
  • group 2: patients with MDD remission after response to an antidepressant treatment.

Exclusion criteria

  • comorbid somatic or psychiatric disorders: chronic or acute inflammatory diseases, previous treatment with brain stimulation for the current episode, legal protection

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

108 participants in 2 patient groups

resistant depression
Other group
Description:
patients suffering from resistant unipolar depression (at least 2 failed antidepressant treatments for the current episode)
Treatment:
Procedure: blood sample
Behavioral: psychometric scales
non resistant depression
Other group
Description:
patients in remission from unipolar depressive disorder
Treatment:
Procedure: blood sample
Behavioral: psychometric scales

Trial contacts and locations

1

Loading...

Central trial contact

Emmanuel Haffen, MD PhD; Julie Monnin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems